E3 Breast Cancer Taxotere Combination

NCT00494481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Vandetanib (ZD6474)
DRUG: Docetaxel

Sponsor

Genzyme, a Sanofi Company